We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go: Stretch investment: Withheld
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go: Extended investment: Withheld
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go: TBC investment: Withheld
Grub Club is London’s No.1 “pop-up” restaurant platform; the USP is “Discover extraordinary experiences in curious corners.” The Grub Club platform brings together professionally trained chefs with unusual, interesting venues to either offer memorable private events or sell tickets for the chef’s own publicly available, themed event for one or more diners. The typical event party size is somewhere between 18-50 people. Grub Club makes its money by charging commission on the overall event cost.
days to go: Expired investment: £35,037
Signature Brew strives to craft beer that enhances the musical experience. Since 2011, their mission has been to create more collaborative beers with bands and musicians than any other brand globally. Through the success of their flagship beers, Studio Lager and Roadie All-Night IPA, they aim to spread their vision of uniting people through exceptional beer, music, and memorable experiences on a national and international scale. Continuing their original objective of improving the beer scene at beloved venues and festivals, Signature Brew remains committed to this ethos. Their direct-to-consumer customer base is expanding across the UK, driven by partnerships with artists and venues within their community. Operating from their cutting-edge brewery in East London, which includes an iconic live music venue, they consistently produce award-winning beer while fervently supporting grassroots music.
days to go: Expired investment: £872,392
Scent & Co is a fragrance subscription service provider that offers choice, portability and flexibility with high-end fragrances at fair prices. Customers get a 30-day supply of 10ml bottle of their choice of fragrance or the choice of scent determined by fragrance experts. Since May 2017, with minimal marketing spend, Scent & Co has attracted 1500 customers and currently, has 850 loyal subscribers. The company has a loan-to-value ratio of £24 while 96% of its revenue is raised from the subscriptions. By next April, it aims to reach 7000 subscribers and to enhance customer experience to reduce churn.
days to go: Expired investment: £12,750
Hawkens Gingerbread is a bakery that makes gingerbread products that are diverse, rich in heritage, delicious, and high in quality. It has spent three years in a start-up phase and now targets a three-year phase of stage one growth. Currently, its facility can bake up to 80,000 units of gingerbread each month. Since 2017, it is consistently producing a 65% average gross profit margin across its B2C and B2B markets. This company has been growing for three years, and in the financial year 2019, its revenue grew 108% to £43k (£25k profit). Its online sales are displaying a strong flow in the upwards direction. Fund raised will enable it to get in front of a much wider audience and bring the necessary skills into the business.
days to go: Expired investment: £67,110
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph